Evidence map›Paper›PMID 41089859›Full record

ArticleFrontiers in public health2025

Estimating proportions of missed children and reasons for non-vaccination following implementation of "reaching the unreached" multiantigen immunization campaign-south Khyber Pakhtunkhwa, Pakistan, July-August 2023.

Amen Ben Hamida, Fawad Alam, Brock Stewart, Shahid Ahmad, Eid Nawaz Sherani, Hafizullah Khan, Akerele Adekunle, Abdinoor Mohamed, Chukwuma Mbaeyi, Richard Franka and 2 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amen Ben HamidaGlobal Immunization Division, U.S. Centers for Disease Control and Prevention (U.S. CDC), Atlanta, GA, United States.
Fawad AlamIntegral Global Health, Islamabad, Pakistan.
Brock StewartGlobal Immunization Division, U.S. Centers for Disease Control and Prevention (U.S. CDC), Atlanta, GA, United States.
Shahid AhmadIntegral Global Health, Islamabad, Pakistan.
Eid Nawaz SheraniKhyber Pakhtunkhwa Province Polio Emergency Operations Centre, Peshawar, Pakistan.
Hafizullah KhanKhyber Pakhtunkhwa Province Polio Emergency Operations Centre, Peshawar, Pakistan.
Akerele AdekunleGlobal Immunization Division, U.S. Centers for Disease Control and Prevention (U.S. CDC), Atlanta, GA, United States.
Abdinoor MohamedGlobal Immunization Division, U.S. Centers for Disease Control and Prevention (U.S. CDC), Atlanta, GA, United States.
Chukwuma MbaeyiGlobal Immunization Division, U.S. Centers for Disease Control and Prevention (U.S. CDC), Atlanta, GA, United States.
Richard FrankaGlobal Immunization Division, U.S. Centers for Disease Control and Prevention (U.S. CDC), Atlanta, GA, United States.
Abdul BasitKhyber Pakhtunkhwa Province Polio Emergency Operations Centre, Peshawar, Pakistan.
Rana SafdarIntegral Global Health, Islamabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During January 2022-June 2023, Pakistan reported 21 Wild Polio Virus 1 (WPV1) cases, all of which occurred within districts in the south Khyber Pakhtunkhwa (KP) province. In May 2023, a special immunization campaign was conducted to reach all children under 5 years of age within 69 high-risk union councils (UCs) in six districts of south KP. The campaign comprised of three rounds, each lasting 8 days, that provided bivalent oral poliovirus vaccine (bOPV) as well as other vaccines using a site-to-site delivery strategy. Rounds 1, 2, and 3 were conducted in July 2023, August 2023, and April 2024, respectively. We conducted a post-campaign evaluation (PCE) survey following the first two rounds, to assess OPV receipt, using a multistage sampling design. We analyzed PCE data for the two first rounds to provide UC-level estimates of the proportions of children who did not receive bOPV and assessed reasons for non-vaccination. The PCE survey included 8,125 children from 67 UCs during round 1 and 7,726 children from 47 UCs during round 2. The median number of villages by UC was 8 for both rounds. The median number of children by village was 16 for round 1 and 19 for round 2. Overall, 16% of children missed bOPV (95% CI = 14-18%) for round 1 [estimated total of 39,983 children (95% CI = 34,775-45,808)]; and 15% (95% CI = 13-17%) for round 2 [estimated total of 24,257 children (95% CI = 21,355-27,474)]. Percentages and numbers of missed children varied widely among UCs during both rounds. Six UCs in the first round and four UCs in the second had ≥40% missed children. Reasons for non-vaccination were similar for each round, with operational reasons leading by >60%, followed by refusals (≥20%), and child not available (~10%). We found a high proportion of missed children during this special immunization intervention and identified the UCs with the greatest challenges. In these UCs, there is a need to design and implement comprehensive, tailored, and effective interventions for each reason why children missed vaccination.

Indexed as

Immunization ProgramsPoliomyelitisPoliovirus Vaccine, OralVaccinationChild, PreschoolFemaleHumansInfantMalePakistanPoliovirus Vaccine, Oralmissed childrenPakistanpoliopolio campaign monitoringsupplementary immunisation activities

Identifiers

PMID41089859
PMCPMC12515884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.